# Regular cannabinoid use and inflammatory biomarkers: Systematic review and hierarchical meta-analysis. > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/cannabis-inflammatory-biomarkers-systematic-review-meta-analysis/ > **Published:** 2026-04-27T16:23:24-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:01:00-04:00 > **Clinical Summary:** New systematic review examines cannabis inflammatory biomarkers across 46 studies. Learn what this research reveals about cannabinoid effects on inflammation. --- CED Clinical Relevance  #100High Clinical Relevance Evidence Brief | CED ClinicRegular cannabinoid use was associated with higher anti-inflammatory biomarker levels in observational studies involving 54,382 participants. InflammationBiomarkersMeta-AnalysisCannabisImmunomodulation Regular cannabinoid use was associated with higher anti-inflammatory biomarker levels in observational studies involving 54,382 participants. What This Study Teaches Us This meta-analysis provides the first systematic synthesis of [cannabinoid effects](https://cedclinic.com/adolescent-cannabis-psychiatric-outcomes-2026-digest/) on inflammatory biomarkers across diverse populations. The finding of increased anti-inflammatory markers in cannabis users suggests a measurable immunomodulatory signal, though the clinical significance remains unclear. Why This Matters With [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) rising for both medical and recreational purposes, understanding its inflammatory effects is clinically relevant for patient counseling. This data helps frame discussions about potential immune system interactions in cannabinoid users. Study Snapshot Study Type [Systematic Review](https://cedclinic.com/cannabinoid-safety-efficacy-mental-health-study/) and Meta-Analysis Population 54,382 participants across 46 studies, including healthy populations and individuals with psychiatric disorders Intervention Regular cannabinoid use Comparator Non-users of cannabinoids Primary Outcome Peripheral inflammatory biomarkers Key Finding [Cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) associated with higher anti-inflammatory biomarker levels in observational studies Journal Brain, Behavior, and Immunity Year 2025 Clinical Bottom Line Regular cannabinoid use appears associated with detectable changes in inflammatory biomarkers, specifically increases in anti-inflammatory markers. However, the clinical meaningfulness of these laboratory changes for health outcomes remains undefined. What This Paper Does Not Show The abstract does not establish whether these biomarker changes translate to meaningful clinical outcomes, disease risk modification, or therapeutic benefit. The direction and magnitude of effects from RCTs and prospective studies are not provided. Where This Paper Deserves Skepticism Observational studies cannot establish causation, and confounding by lifestyle factors, underlying conditions, or co-substance use may explain associations. The heterogeneity across 46 studies likely introduces significant methodological variability. Dr. Caplan's Take I see inflammatory biomarker changes regularly in my cannabis patients, but I’ve never been able to connect these lab findings to meaningful clinical outcomes. This meta-analysis confirms there’s a measurable signal, but it doesn’t change how I counsel patients about cannabis and inflammation. What a Careful Reader Should Take Away Cannabinoid use produces detectable changes in inflammatory biomarkers, but the clinical relevance remains uncertain. These findings support the biological plausibility of immune modulation but don’t establish therapeutic utility or safety implications. Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-industry/) Have thoughts on this? Share it: [X Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Regular%20cannabinoid%20use%20and%20inflammatory%20biomarkers%3A%20Systematic%20review%20and%20hierarchical%20meta-analysi...%20%40drcaplan&url=https%3A%2F%2Fcedclinic.com%2Fcannabis-inflammatory-biomarkers-systematic-review-meta-analysis%2F)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcedclinic.com%2Fcannabis-inflammatory-biomarkers-systematic-review-meta-analysis%2F)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Regular%20cannabinoid%20use%20and%20inflammatory%20biomarkers%3A%20Systematic%20review%20and%20hierarchical%20meta-analysi...%20via%20%40drcaplan.bsky.social%20https%3A%2F%2Fcedclinic.com%2Fcannabis-inflammatory-biomarkers-systematic-review-meta-analysis%2F)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan)[📝 Read more on Substack](https://doctorapprovedcannabis.substack.com/)[🔔 Subscribe via RSS](https://cedclinic.com/feed/) Table of Contents - [FAQ](#FAQ)[Does regular cannabis use affect inflammatory markers in the body?](#Does_regular_cannabis_use_affect_inflammatory_markers_in_the_body) - [Should I be concerned about inflammation if I use cannabis regularly?](#Should_I_be_concerned_about_inflammation_if_I_use_cannabis_regularly) - [Are the anti-inflammatory effects of cannabis supported by clinical trials?](#Are_the_anti-inflammatory_effects_of_cannabis_supported_by_clinical_trials) - [Does cannabis use affect inflammation differently in people with psychiatric disorders?](#Does_cannabis_use_affect_inflammation_differently_in_people_with_psychiatric_disorders) - [How reliable is this evidence for clinical decision-making?](#How_reliable_is_this_evidence_for_clinical_decision-making) - [Related](#Related) ## FAQ #### Does regular cannabis use affect inflammatory markers in the body? Yes, this meta-analysis of 46 studies involving over 54,000 participants found that regular cannabis use is associated with higher levels of anti-inflammatory biomarkers. This suggests cannabis may have an anti-inflammatory effect at the systemic level, though the clinical significance of these changes requires further investigation. #### Should I be concerned about inflammation if I use cannabis regularly? Based on current evidence, regular cannabis use appears to be associated with increased anti-inflammatory rather than pro-inflammatory markers, which may actually be beneficial. However, individual responses can vary, and patients with existing inflammatory conditions should discuss cannabis use with their healthcare provider. #### Are the anti-inflammatory effects of cannabis supported by clinical trials? The study included data from randomized controlled trials, though the majority of evidence comes from observational studies. While the findings suggest [anti-inflammatory effects](https://cedclinic.com/cbd-antioxidative-anti-inflammatory-properties-benefits/), more high-quality [clinical trials](https://cedclinic.com/endocannabinoid-system-emotional-memory-ptsd-treatment/) are needed to establish definitive therapeutic recommendations for inflammatory conditions. #### Does cannabis use affect inflammation differently in people with psychiatric disorders? The study specifically examined whether cannabinoids affect inflammation in both healthy populations and individuals with psychiatric disorders. However, the summary doesn’t provide clear distinctions between these groups, indicating more research is needed to understand population-specific effects. #### How reliable is this evidence for clinical decision-making? This [systematic review](https://cedclinic.com/cannabinoid-safety-efficacy-mental-health-study/) and meta-analysis represents high-quality evidence synthesis from 46 studies with a large participant pool. However, the predominance of observational data means causation cannot be definitively established, and clinical applications should be considered carefully alongside other patient factors. [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).